Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.98
1.09%
After-hours: Aug 15, 2025, 06:13 PM EDT

Rigel Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
16.91 -10.06 -4.42 -25.22
PEG Ratio
-0.1 0.17 -0.02 0.61
PS Ratio
1.65 2.16 2.15 3.03
PB Ratio
89.93 -8.81 -18.99 14.87
P/FCF Ratio
9.41 -12.16 -3.49 86.04
P/OCF Ratio
9.40 -43.94 -3.51 76.86
OCF/S Ratio
0.18 -0.05 -0.61 0.04
Debt / Equity Ratio
18.24 -2.11 -3.05 1.01
Quick Ratio
2.04 1.76 1.64 2.33
Current Ratio
2.13 1.86 1.78 2.43
Asset Turnover
1.09 1.00 0.90 0.89
Interest Coverage
3.06 -2.98 -14.99 -1.85
Return on Equity
5.32 0.88 4.30 -0.59
Return on Assets
0.11 -0.21 -0.44 -0.11
Return on Invested Capital
0.21 -0.28 -0.78 -0.08
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.90 0.94 0.99 0.99
Net Profit Margin
0.10 -0.21 -0.49 -0.12
Pretax Profit Margin
0.10 -0.21 -0.49 -0.12
Operating Profit Margin
0.13 -0.18 -0.46 -0.06
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.16 -0.15 -0.45 -0.08